133 related articles for article (PubMed ID: 32343917)
1. Gene Prioritization in Parkinson's Disease Using Human Protein-Protein Interaction Network.
Prajapati R; Emerson IA
J Comput Biol; 2020 Nov; 27(11):1610-1621. PubMed ID: 32343917
[TBL] [Abstract][Full Text] [Related]
2. Construction of Parkinson's disease marker-based weighted protein-protein interaction network for prioritization of co-expressed genes.
George G; Valiya Parambath S; Lokappa SB; Varkey J
Gene; 2019 May; 697():67-77. PubMed ID: 30776463
[TBL] [Abstract][Full Text] [Related]
3. Gene co-expression network analysis for identifying genetic markers in Parkinson's disease - a three-way comparative approach.
George G; Singh S; Lokappa SB; Varkey J
Genomics; 2019 Jul; 111(4):819-830. PubMed ID: 29852216
[TBL] [Abstract][Full Text] [Related]
4. Construction and analysis of the protein-protein interaction networks based on gene expression profiles of Parkinson's disease.
Rakshit H; Rathi N; Roy D
PLoS One; 2014; 9(8):e103047. PubMed ID: 25170921
[TBL] [Abstract][Full Text] [Related]
5. Multimodal analysis of gene expression from postmortem brains and blood identifies synaptic vesicle trafficking genes to be associated with Parkinson's disease.
Gao X; Huang Z; Feng C; Guan C; Li R; Xie H; Chen J; Li M; Que R; Deng B; Cao P; Li M; Lu J; Huang Y; Li M; Yang W; Yang X; Wen C; Liang X; Yang Q; Chao YX; Chan LL; Yenari MA; Jin K; Chaudhuri KR; Zhang J; Tan EK; Wang Q
Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33079984
[TBL] [Abstract][Full Text] [Related]
6. Advances in protein-protein interaction network analysis for Parkinson's disease.
Tomkins JE; Manzoni C
Neurobiol Dis; 2021 Jul; 155():105395. PubMed ID: 34022367
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of public microarray data identifies biological regulatory networks in Parkinson's disease.
Su L; Wang C; Zheng C; Wei H; Song X
BMC Med Genomics; 2018 Apr; 11(1):40. PubMed ID: 29653596
[TBL] [Abstract][Full Text] [Related]
8. Biological networks in Parkinson's disease: an insight into the epigenetic mechanisms associated with this disease.
Chatterjee P; Roy D; Bhattacharyya M; Bandyopadhyay S
BMC Genomics; 2017 Sep; 18(1):721. PubMed ID: 28899360
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of Gene Expression and Regulatory Network Interaction Data Reveals the Protein Kinase C Family of Serine/Threonine Receptors as a Significant Druggable Target for Parkinson's Disease.
Odumpatta R; Arumugam M
J Mol Neurosci; 2021 Mar; 71(3):466-480. PubMed ID: 32728898
[TBL] [Abstract][Full Text] [Related]
10. Identification of potential genomic biomarkers for Parkinson's disease using data pooling of gene expression microarrays.
Lin Z; Zhou L; Li Y; Liu S; Xie Q; Xu X; Wu J
Biomark Med; 2021 Jun; 15(8):585-595. PubMed ID: 33988461
[No Abstract] [Full Text] [Related]
11. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
12. Identification of Biomolecular Information in Rotenone-Induced Cellular Model of Parkinson's Disease by Public Microarray Data Analysis.
Yu F; Le ZS; Chen LH; Qian H; Yu B; Chen WH
J Comput Biol; 2020 Jun; 27(6):888-903. PubMed ID: 31593492
[TBL] [Abstract][Full Text] [Related]
13. miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson's disease.
Liu X; Chen J; Guan T; Yao H; Zhang W; Guan Z; Wang Y
BMC Syst Biol; 2019 Jan; 13(1):10. PubMed ID: 30665415
[TBL] [Abstract][Full Text] [Related]
14. Identification of crucial genes associated with Parkinson's disease using microarray data.
Sun Y; Ye L; Zheng Y; Yang Z
Mol Med Rep; 2018 Mar; 17(3):3775-3782. PubMed ID: 29257331
[TBL] [Abstract][Full Text] [Related]
15. Progression Rate Associated Peripheral Blood Biomarkers of Parkinson's Disease.
Fan Y; Xiao S
J Mol Neurosci; 2018 Jul; 65(3):312-318. PubMed ID: 29936662
[TBL] [Abstract][Full Text] [Related]
16. Transcriptomic profiling of differentially expressed genes and related pathways in different brain regions in Parkinson's disease.
Jia E; Pan M; Liu Z; Zhou Y; Zhao X; Dong J; Bai Y; Ge Q
Neurosci Lett; 2020 Jul; 732():135074. PubMed ID: 32446776
[TBL] [Abstract][Full Text] [Related]
17. Detecting pathway relationship in the context of human protein-protein interaction network and its application to Parkinson's disease.
Hu Y; Yang Y; Fang Z; Hu YS; Zhang L; Wang J
Methods; 2017 Dec; 131():93-103. PubMed ID: 28790017
[TBL] [Abstract][Full Text] [Related]
18. Identification of Critical Genes and miRNAs Associated with the Development of Parkinson's Disease.
Li J; Sun Y; Chen J
J Mol Neurosci; 2018 Aug; 65(4):527-535. PubMed ID: 30083784
[TBL] [Abstract][Full Text] [Related]
19. An Integrated Network Analysis of mRNA and Gene Expression Profiles in Parkinson's Disease.
Wang Y; Wang Z
Med Sci Monit; 2020 Mar; 26():e920846. PubMed ID: 32210219
[TBL] [Abstract][Full Text] [Related]
20. Identifying the Association Between Alzheimer's Disease and Parkinson's Disease Using Genome-Wide Association Studies and Protein-Protein Interaction Network.
Liu G; Bao X; Jiang Y; Liao M; Jiang Q; Feng R; Zhang L; Ma G; Chen Z; Wang G; Wang R; Zhao B; Li K
Mol Neurobiol; 2015 Dec; 52(3):1629-1636. PubMed ID: 25370933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
